Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
41 Results Found
AHA files briefs in defense of Louisiana's 340B contract pharmacy law
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
Minnesota court dismisses PhRMA lawsuit challenging state 340B law
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements.
White House issues executive order on drug pricing
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
HHS files brief in 340B rebate model case
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed March 17 with the United States District Court for the District of Columbia.
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
The AHA has filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject drug companies’ proposed 340B rebate models in separate lawsuits brought by a number of drug companies to bar the agency from doing so.
AHA files amicus brief in 4th Circuit in support of Maryland 340B contract pharmacy law
The AHA Feb.
AHA, others file amicus brief opposing J&J 340B rebate model
The AHA Feb. 28 filed a friend-of-the-court brief (https://www.aha.org/amicus-brief/2025-02-28-aha-others-file-amicus-brief-opposing-jj-340b-rebate-model) in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.
Washington update panel discusses legislative priorities for rural health care
AHA President and CEO Rick Pollack joined AHA’s Chad Golder, senior vice president and general counsel, Travis Robey, vice president of political affairs, and Shannon Wu, director of payment policy, for a discussion on the ever-shifting landscape of health care affairs on Capitol Hill.
HRSA directs Sanofi to cease implementing unapproved 340B rebate proposalÂ
The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate proposal immediately and to inform HRSA of its plans no later than Dec. 20 in order to provide adequate notice to covered entities.
Research finds drug prices increased without adding new clinical benefits
The net prices of five drugs included in a new study from the Institute for Clinical and Ec